Biomarkers of 5-FU response in colon cancer

被引：3
|
作者：
Mariadason, John M. [1 ]
Tebbutt, Niall C. [1 ]
机构：
[1] Austin Hlth, Ludwig Inst Canc Res, Heidelberg, Vic, Australia
来源：
CANCER BIOLOGY & THERAPY | 2011年 / 11卷 / 08期
关键词：
5-FU; biomarkers; colon cancer; chemotherapy; CTPS2; COLORECTAL-CANCER; 5-FLUOROURACIL; RESISTANCE;
D O I：
10.4161/cbt.11.8.15109
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [1] Efficacy of adjuvant chemotherapy with 5-FU/leucovorin and 5-FU/levamisole colon cancer
    Porschen, R
    Bermann, A
    Löffler, T
    Haack, G
    Rettig, K
    Anger, Y
    Strohmeyer, G
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A664 - A664
  • [2] CARDIOTOXICITY OF 5-FU DURING ADJUVANT CHEMOTHERAPY IN CANCER OF COLON
    BUGNON, PY
    ELHAGE, A
    BOUNOUA, F
    GAUTIERBENOIT, C
    [J]. BULLETIN DU CANCER, 1992, 79 (04) : 365 - 367
  • [3] UFT/leucovorin vs 5-FU/leucovorin in colon cancer
    Smith, RE
    Lembersky, BC
    Wieand, HS
    Colangelo, L
    Mamounas, EP
    [J]. ONCOLOGY-NEW YORK, 2000, 14 (10): : 24 - 27
  • [4] Colon cancer: New drug options improve on 5-FU
    McCann, J
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (13) : 963 - 965
  • [5] Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy
    Shebzukhov, YV
    Koroleva, EP
    Khlgatian, SV
    Lagarkova, MA
    Meshcheryakov, AA
    Lichinitser, MR
    Karbach, J
    Jager, E
    Kuprash, DV
    Nedospasov, SA
    [J]. IMMUNOLOGY LETTERS, 2005, 100 (01) : 88 - 93
  • [6] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    De Angelis, Paula M.
    Svendsrud, Debbie H.
    Kravik, Katherine L.
    Stokke, Trond
    [J]. MOLECULAR CANCER, 2006, 5 (1)
  • [7] Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
    Paula M De Angelis
    Debbie H Svendsrud
    Katherine L Kravik
    Trond Stokke
    [J]. Molecular Cancer, 5
  • [8] Hemodialysis improves 5-FU induced hypreanmonemia with depressed level of conciousness with during 5-FU containing regimen for colon cancer
    Watanabe, Toshiyasu
    Kijima, Sho
    Goto, Mayu
    Koiso, Yasuhiro
    Kawagoe, Naoyuki
    Takemoto, Ikutaka
    Maeda, Tadashi
    Miyazaki, Taito
    Kido, Hidenori
    Honda, Yoshiko
    Kikuchi, Yoshinori
    Ogura, Mariko
    Koike, Junichi
    Shinozaki, Eiji
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Funahashi, Kimihiko
    Shimada, Nagato
    Nakajima, Hitoshi
    Urita, Yosihisa
    Shimada, Hiedeaki
    Kaneko, Hironori
    Mizunuma, Nobuyuki
    Sugimoto, Motonobu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 336 - 337
  • [9] TREATMENT OF METASTATIC COLON CANCER WITH 5-FU, MECCNU, BCG AND LEUCOVORIN
    TISMAN, G
    WU, SJ
    HITTLE, T
    STEVENS, T
    FOX, M
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 217 - 217
  • [10] 5-FU schedules, serum 5-FU levels and their relationship to therapy response and toxicity in patients with gastrointestinal cancer
    Blaschke, Martina
    Cameron, Silke
    Goeschen, Colin
    Ramadori, Giuliano
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 56 - 58
12345